HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reappraisal of surgical indications and approach for liver hemangioma: single-center experience on 74 patients.

AbstractBACKGROUND:
Liver hemangiomas are rarely large, symptomatic, or presenting atypical imaging patterns. Surgery is rarely needed; indications and choice of the best technique remain not precisely defined.
METHODS:
Features of hemangiomas and surgical indications were assessed in 74 patients (mean follow-up 63.2 months). In 40 operated patients, the results of liver resection versus enucleation were compared.
RESULTS:
Most hemangiomas (60/74, 81.1%) showed no size increment. In 40 operated patients (40/74, 54.1%) the mean tumor size (11.9 cm, range 2.6-46.0) was larger than in nonoperated patients (11.9 vs 6.0 cm, P = .0002). Surgical indications were specific symptoms, tumor enlargement, Kasabach-Merritt syndrome, and uncertain diagnosis. Mortality (nil), morbidity (10.0%), and transfusion rate (15.0%) were similar for 28 liver resections versus 12 enucleations; bleeding was more related to large hemangioma size than to the choice of either technique. Liver ischemia techniques, autotransfusion, and intraoperative blood salvage reduced the risk of transfusion.
CONCLUSIONS:
Surgery is rarely indicated, has a low risk, and has similar results for liver resection versus enucleation. Risk of bleeding is related more to the large size of the hemangioma than to the type of surgery (resection or enucleation). In these patients, management, the need for surgery, and the choice of technique should be carefully individualized.
AuthorsFelice Giuliante, Francesco Ardito, Maria Vellone, Marco Giordano, Giuseppina Ranucci, Micaela Piccoli, Ivo Giovannini, Carlo Chiarla, Gennaro Nuzzo
JournalAmerican journal of surgery (Am J Surg) Vol. 201 Issue 6 Pg. 741-8 (Jun 2011) ISSN: 1879-1883 [Electronic] United States
PMID20937504 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • Blood Loss, Surgical (prevention & control)
  • Female
  • Follow-Up Studies
  • Hemangioma (diagnosis, epidemiology, surgery)
  • Hepatectomy (methods)
  • Humans
  • Liver Neoplasms (diagnosis, epidemiology, surgery)
  • Male
  • Middle Aged
  • Morbidity (trends)
  • Prognosis
  • Prospective Studies
  • Survival Rate (trends)
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: